Steno2tech - Continuous Glucose Monitoring and Type 2 Diabetes.
Steno2tech CGM-The Effect of Real-time Continuous Glucose Monitoring vs. Self-monitoring of Blood Glucose on Glycemic Variables and Patient Reported Outcomes in Adults With Type 2 Diabetes Treated With Insulin-A Randomized Controlled Trial.
Sponsor: Steno Diabetes Center Copenhagen
Listed as NCT04331444, this NA trial focuses on Type 2 Diabetes Treated With Insulin and remains completed. Sponsored by Steno Diabetes Center Copenhagen, it has been updated 12 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Nov 2023 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Feb 2023 — Nov 2023 [monthly]
Active Not Recruiting NA
▶ Show 7 earlier versions
-
Jun 2022 — Feb 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Jun 2022 [monthly]
Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
-
Aug 2020 — Sep 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jul 2020 — Aug 2020 [monthly]
Not Yet Recruiting NA
-
Jun 2020 — Jul 2020 [monthly]
Not Yet Recruiting NA
-
May 2020 — Jun 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Steno Diabetes Center Copenhagen
For direct contact, visit the study record on ClinicalTrials.gov .